These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6803310)

  • 1. Anti-aggregatory actions of calcium channel blockers in cat platelets.
    Schmunk GA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):179-87. PubMed ID: 6803310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
    Lippton HL; Horwitz PM; McNamara DB; Landry AZ; Kadowitz PJ
    Prostaglandins Leukot Med; 1984 Oct; 16(1):121-30. PubMed ID: 6440150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME; Renzulli LA
    Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM; Sloane BF; Honn KV
    Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibiting action of anti-arrhythmia agents of the phenothiazine series--etmozin and its diethylamino analog--on platelet aggregation and metabolism of endogenous arachidonic acid].
    Mazurov AV; Leĭtin VL; Repin VS; Rozenshtraukh LV; Smirnov VN
    Biull Eksp Biol Med; 1984 Jan; 97(1):63-5. PubMed ID: 6419795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.
    Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
    Drugs Exp Clin Res; 1985; 11(9):645-51. PubMed ID: 3939725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium channel-blocking agents on platelet-osteogenic sarcoma interaction: platelet aggregation and electron microscopic findings.
    Mehta P; Kimura A; Lawson D
    J Orthop Res; 1990 Sep; 8(5):629-34. PubMed ID: 2388101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit.
    Osborne JA; Darius H; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):167-78. PubMed ID: 3715198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
    el Tahir KE; el-Naser MA; Ageel AM; el-Obeid HA; al-Rashood KA
    Arch Int Pharmacodyn Ther; 1990; 307():162-71. PubMed ID: 2095711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
    Jones CR; Pasanisi F; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA; Johnson PC; Smith M; Salzman EW
    Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human rhabdosarcoma cell-induced aggregation of blood platelets.
    Longenecker GL; Beyers BJ; Bowen RJ; King T
    Cancer Res; 1989 Jan; 49(1):16-9. PubMed ID: 2491750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.
    Zhang QH; Das K; Siddiqui S; Myers AK
    Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB; Fuller BL; Falotico R; Tolman EL
    Thromb Res; 1985 Nov; 40(3):401-11. PubMed ID: 2417362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H
    Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
    Ivleva AIa; Kobalava ZhD; Moiseev VS
    Farmakol Toksikol; 1989; 52(2):77-80. PubMed ID: 2568273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation: inhibition of secondary aggregation by phenol.
    Coan ML; Case KR; Bosmann HB
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):241-9. PubMed ID: 6808618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro.
    Wang LL; Mei QB; Zhao DH; Guo ZA
    Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.